Sign up for the latest news
You can unsubscribe at any time using the link at the bottom of any newsletter or contacting info@predictimmune.com
Stay up to date with the latest technology, conference and funding news from PredictImmune.
PredictImmune co-founder to present T-Cell Exhaustion, Co-Stimulation and Clinical Outcome in Autoimmunity and Infection at Keystone Symposia, USA
PredictImmune co-founder to present T-Cell Exhaustion, Co-Stimulation and Clinical Outcome in Autoimmunity and Infection at Keystone Symposia, USA Cambridge, UK, 3rd January 2019: Professor Kenneth Smith, one of PredictImmune’s founders and Head of the Department of...
PredictImmune’s first prognostic test, PredictSURE IBD™, set for UK and European launch having been awarded CE mark
PredictImmune’s first prognostic test, PredictSURE IBD™, set for UK and European launch having been awarded CE mark Achievement marks significant progress towards improving treatment and outcomes for IBD patients in the UK and Europe Cambridge, UK, December...
Crohn’s Disease PROFILE Trial Protocol Published
Crohn’s Disease PROFILE Trial Protocol Published PredictImmune is pleased to announce the e-publication of the PRedicting Outcomes For Crohn’s dIsease using a moLecular biomarker (PROFILE) trial protocol in the BMJ. Cambridge, UK, 06 December 2018: The PROFILE...
PredictImmune joins the British In Vitro Device Association (BIVDA)
PredictImmune joins the British In vitro Device Association (BIVDA) Cambridge, UK, 13th November 2018: With the launch of its first product imminent, PredictImmune has joined the national IVD industry association to support its development as it continues to...
PredictImmune’s prognostic biomarker for inflammatory bowel disease (IBD) and the PROFILE study to feature at meetings on both sides of the Atlantic in November
PredictImmune’s prognostic biomarker for inflammatory bowel disease (IBD) and the PROFILE study to feature at meetings on both sides of the Atlantic in November. Cambridge, UK, 9th November 2018: There will be two opportunities to hear about PredictImmune’s...
PredictImmune founders to present at Immunology of Diabetes Society Congress 2018.
PredictImmune founders, Professor Ken Smith and Dr Eoin McKinney to present at Immunology of Diabetes Society Congress 2018. Cambridge, UK, 16th October 2018: The end of October sees the return of the Immunology of Diabetes Society for their 16th congress, and...
PredictImmune’s CSO, Dr Eoin McKinney and University of Cambridge colleague, Dr James Lee, presenting at the UEG Week Course in Vienna.
PredictImmune’s CSO, Dr Eoin McKinney and University of Cambridge colleague, Dr James Lee, presenting at the UEG Week Course in Vienna. Cambridge, UK, 8th October 2018: October offers a great opportunity to hear more about the impact of prognostication on...
PredictImmune: Announced as Finalist in the Cambridge Independent Science & Technology Awards
PredictImmune: Announced as Finalist in the Cambridge Independent Science & Technology Awards Cambridge, UK, 14th September 2018: PredictImmune is pleased to be selected as one of the finalists, in the “start up of the year” category of the Cambridge...
PredictImmune’s Prognostic Biomarker Test for IBD to feature in Platform Presentations at Upcoming Conferences
PredictImmune’s Prognostic Biomarker Test for IBD to feature in Platform Presentations at Upcoming Conferences Cambridge, UK, 17th September 2018: PredictImmune’s first product, a prognostic biomarker test for IBD will be the subject of two key presentations at...
PredictImmune joins the Babraham Research Campus community
PredictImmune join the Babraham Research Campus community Developer of pioneering tools for guiding treatment options in immune-mediated inflammatory diseases choose Babraham Research Campus as permanent base within the Cambridge Cluster Babraham, 14th May 2018: The...